Formulation and Development of Bilayer Floating Tablet of Amoxicillin

  • Priyanka Jartolia Sun Institute of Pharmaceutical Education and Research, Lahar
  • Sapna Avinash Kondalkar Sun Institute of Pharmaceutical Education and Research, Lahar
  • Avinash Krishnrao Kondalkar Sun Institute of Pharmaceutical Education and Research, Lahar
  • Muraree Lal Sun Institute of Pharmaceutical Education and Research, Lahar
DOI https://doi.org/10.24092/CRPS.2020.100403

Abstract

Bilayer floating tablet of amoxicillin was formulated successfully and evaluated under suitable parameters. All the batches of tablet produced were found to exhibit short floating lag times. The tablet of batch F2 exhibited a longer floating lag time of 23 minutes. Relationship between the dependent and independent variables was further elucidated using contour and response surface plots. Dissolution profiles that the tablets of batch F3, F7, and F12 exhibits initial burst phase during the first hour of dissolution. The burst phase was followed by a limited drug release for the rest of the period. Also it was observed during the dissolution studies that tablets of all three batches eroded quickly with increased effervescence. Time required for 50 % drug to get released (T50%) and %CR10hrs were found to be in the range of 0.7 to 8.6 hours and 57.35 ± 3.89 to 99.93 ± 0.07 respectively, value of “Prob > F” less than 0. 05. Response surface plots and Contour plot indicated that at a fixed level of B (35 mg) and low level of A (amount of HPMC), % CR10hrs increases from 68.11 to 90.00 % and T50% decrease from 6.86 to 1.66 as the amount of citric acid (C) increases from 0 to 10 mg. Stability study was performed for optimized formulation and it was found that formulation was stable for 6 week at 25 °C/ 60% RH.

Keywords: Bilayer floating tablet, amoxicillin, Evaluated, Multi-layered tablet, Stability

References

1. Fendrick AK, Forsch RT, Harrison RV, Scheiman JM. Pepticulcer guideline team, University of Michigan Guidelines for Health System. 2005. http://www.stjames.ie/GPsHealthcareProfessionals/Newsletters/NMICBulletins/NMICBulletins1995/VOL1-3.pdf. Updated May 2005.
2. Hoffmana A, Danenbergb HD, Katzhendlera I, Shuvala R, Gilhar
D, Friedman M. Pharmacodynamic and pharmacokinetic rationales
for the development of an oral controlled-release amoxicillin dosage form. J Control Release. 1998; 54:29–37.
3. P. Dinesh Kumar, Grace Rathnam, C.R. Prakash, G.Saravanan, V. Karthick and T. PanneerSelvam,“Formulation and characterization of bilayer floating tablets of ranitidine”, Rasayan J Chemistry. 2010,3(2) 368-374.
4. Desai, S., Bolton, S. “A floating controlled release drug delivery system: in vitro- in vivo evaluation”. PharmRes. 1993,10(9), 1321-1325.
5. Maniya Shrikant, Shreeraj Shah, Pratik Upadhay. “Floating bilayer drug delivery systems- An unconventionalapproach in conventional form”. Am. J. PharmTech Res, 2012, 2(2),609-628.
6. Hamman JH. Composition and applications of Aloe vera leaf gel.Molecules. 2008; 13:1599–616.
7. Shaila L, Pandey S and Udupa N. Design and Evaluation of Matrix Type Membrane ControlledTransdermal Drug Delivery System of NicotinSuitable for Use in Smoking Cessation. IndianJourn. Pharm. Sci. 2006; 68: 179-184.
Statistics
401 Views | 390 Downloads
How to Cite
Priyanka Jartolia, Sapna Avinash Kondalkar, Avinash Krishnrao Kondalkar, and Muraree Lal. “Formulation and Development of Bilayer Floating Tablet of Amoxicillin”. Current Research in Pharmaceutical Sciences, Vol. 10, no. 4, Mar. 2022, pp. 76-89, doi:10.24092/CRPS.2020.100403.
Issue
Volume 10 Issue 4 (October-December, 2020)
Section
Research Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.